Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
In Vivo
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
In Vivo

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin
Research Article

The Hepoxilin Analog, PBT-3, Inhibits Growth of K-562 CML Solid Tumours In Vivo in Nude Mice

XIANG LI, NA QIAO, DENIS REYNAUD, MOHAMED ABDELHALEEM and CECIL R. PACE-ASCIAK
In Vivo January 2005, 19 (1) 185-189;
XIANG LI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
NA QIAO
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DENIS REYNAUD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MOHAMED ABDELHALEEM
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
CECIL R. PACE-ASCIAK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: pace{at}sickkids.ca
  • Article
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 19 no. 1 185-189
PMID 
15796172

Published By 
International Institute of Anticancer Research
Print ISSN 
0258-851X
Online ISSN 
1791-7549
History 
  • Received November 3, 2004
  • Accepted November 23, 2004
  • Published online January 1, 2005.

Copyright & License 
Copyright © 2005 The Author(s). Published by the International Institute of Anticancer Research.

Author Information

  1. XIANG LI1,
  2. NA QIAO1,
  3. DENIS REYNAUD1,
  4. MOHAMED ABDELHALEEM2 and
  5. CECIL R. PACE-ASCIAK1,3
  1. 1Research Institute Programs in Integrative Biology, The Hospital for Sick Children, Toronto, M5G 1X8
  2. 2Research Institute Programs in Cancer Research, The Hospital for Sick Children, Toronto, M5G 1X8
  3. 3Department of Pharmacology, Faculty of Medicine, University of Toronto, Toronto, Canada M5S 1A8
  1. Correspondence to: Prof. C.R. Pace-Asciak, Programme in Integrative Biology, Research Institute, Rm 6018, The Hospital for Sick Children, 555 University Avenue, Toronto, Ontario, Canada M5G 1X8. Fax: (416) 813-5755, e-mail: pace{at}sickkids.ca

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

PreviousNext
Back to top

In this issue

In Vivo
Vol. 19, Issue 1
January-February 2005
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Ed Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on In Vivo.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The Hepoxilin Analog, PBT-3, Inhibits Growth of K-562 CML Solid Tumours In Vivo in Nude Mice
(Your Name) has sent you a message from In Vivo
(Your Name) thought you would like to see the In Vivo web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
1 + 7 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
The Hepoxilin Analog, PBT-3, Inhibits Growth of K-562 CML Solid Tumours In Vivo in Nude Mice
XIANG LI, NA QIAO, DENIS REYNAUD, MOHAMED ABDELHALEEM, CECIL R. PACE-ASCIAK
In Vivo Jan 2005, 19 (1) 185-189;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
The Hepoxilin Analog, PBT-3, Inhibits Growth of K-562 CML Solid Tumours In Vivo in Nude Mice
XIANG LI, NA QIAO, DENIS REYNAUD, MOHAMED ABDELHALEEM, CECIL R. PACE-ASCIAK
In Vivo Jan 2005, 19 (1) 185-189;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • No citing articles found.
  • Google Scholar
In Vivo

© 2026 In Vivo

Powered by HighWire